Parkman Healthcare Partners’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-222,943
| Closed | -$1.71M | – | 100 |
|
|
2024
Q1 | $1.71M | Buy |
222,943
+10,511
| +5% | +$80.5K | 0.21% | 88 |
|
|
2023
Q4 | $905K | Buy |
212,432
+36,536
| +21% | +$156K | 0.13% | 80 |
|
|
2023
Q3 | $739K | Buy |
175,896
+7,106
| +4% | +$29.8K | 0.14% | 95 |
|
|
2023
Q2 | $940K | Buy |
168,790
+43,790
| +35% | +$244K | 0.16% | 87 |
|
|
2023
Q1 | $716K | Buy |
+125,000
| New | +$716K | 0.16% | 75 |
|